Shandong Chenghui Shuangda Pharma (est. 2014) A rapidly growing API/CDMO leader with 200+ synthesis patents and 100MT monthly capacity across 6 cGMP facilities. Holding 22 CDE, 4 FDA DMF, 8 CEP approvals plus NMPA/MFDS/USFDA certifications. Serving 60+ countries with advanced intermediates and custom manufacturing solutions. Third-party patented products for R&D use only
